Skip to main content

Table 1 Background characteristics of the study participants

From: Associations between pulmonary congestion on chest ultrasound and survival in hemodialysis patients

Characteristic

Quantity

Gender (M/F)

29/32

Age (year)

75.2 ± 10.7

Duration of HD (year)

6.2 ± 8.4

Primary cause of ESKD, n (%)

 Chronic glomerulonephritis

10 (16.4)

 Diabetic nephropathy

28 (45.9)

 Nephrosclerosis

13 (21.3)

 Unknown and others

10 (16.4)

Hypertension, n (%)

53 (86.9)

Diabetes mellitus, n (%)

28 (45.9)

Dyslipidemia, n (%)

11 (18.0)

Atrial fibrillation, n (%)

8 (13.1)

Body weight (kg)

52.3 ± 10.8

Systolic blood pressure (mmHg)

145 ± 26

Diastolic blood pressure (mmHg)

74 ± 15

Heart rate (beat/min)

75 ± 13

Albumin (g/dL)

3.1 ± 0.6

Urea nitrogen (mg/dL)

50.0 ± 17.9

Creatinine (mg/dL)

7.3 ± 2.6

Sodium (mEq/L)

137 ± 4

C-reactive protein (mg/dL)

1.06 ± 2.19

Hemoglobin (g/dL)

10.4 ± 1.3

NT-proBNP (pg/mL)

13,851 (4764–34,279)

LVDd (mm)

45.7 ± 7.0

LVDs (mm)

30.8 ± 7.8

LVEF (%)

60.1 ± 13.4

Maximum WT (mm)

11.5 ± 1.7

UFR (kg/h)

0.51 ± 0.24

UFR/BW (1/h)

0.99 ± 0.42

ΔB-lines/pre B-lines

0.59 ± 0.22

  1. Mean ± SD median (interquartile range), HD hemodialysis, ESKD end-stage kidney disease, LVDd left ventricular end-diastolic dimension, LVDs left ventricular end-systolic dimension, LVEF left ventricular ejection fraction, WT wall thickness, UFR ultrafiltration rate, BW body weight